
Corinnova: Pioneering healthcare solutions for congestive heart failure treatment.
Founded with the mission to revolutionize heart failure treatment, Corinnova is pioneering healthcare solutions with a focus on congestive heart failure. The company's core product is a breakthrough minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure. This innovative technology aims to address the needs of the short-term cardiac assist market, providing a critical solution for patients requiring up to seven days of support.
Corinnova has garnered significant attention and investment, notably from the Wellcome Trust, underscoring the potential impact of its technology. The company has achieved promising preclinical results, positioning itself as a leader in cardiac assist devices. By advancing this novel approach to heart failure treatment, Corinnova is poised to make a substantial impact on patient outcomes and the broader healthcare landscape.

Corveus Medical
corveusmedical.com

CoraVie Medical
coraviemedical.com

Viacor

Reprieve Cardiovascular
reprievecardio.com

Ancora Heart
ancoraheart.com

Corisma MCS Systems
corismacv.com

MedNews

4C Medical Technologies
4cmed.com

Cardiac Dimensions
Neocardial Technologies
neocardial.com

InterShunt
intershunt.com

Procyrion

InnovaCor

ReliantHeart
reliantheart.com

Renata Medical
renatamedical.com
Companies similar to Corinnova include Corveus Medical, CoraVie Medical, Viacor and Reprieve Cardiovascular.
Corinnova was founded in 2004.
Corinnova's headquarters is located in Houston, TX, US.
Corinnova's most recent funding round was for $994k (USD) in November 2021.
As of Nov 30, 2021, Corinnova has raised a total of $7.3M (USD).
Corinnova has 749 employees as of Feb 5, 2024.